ArticleCommunications biology2026
Hippocampal astrocytic GAT-3 blockade impairs protein synthesis and spatial memory dynamics.
Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Astrocytes are essential components of the tripartite synapse, where they modulate synaptic function and plasticity. One key mechanism involves GABA transporter GAT-3, primarily expressed in astrocytes, which helps terminate GABAergic signaling and maintain synaptic homeostasis. We studied the role of hippocampal GAT-3 in spatial memory dynamics using the spatial object recognition (SOR) task in female Wistar rats. GAT-3 inhibition with SNAP-5114 (SNAP) in the dorsal hippocampus impaired memory consolidation without affecting acquisition. This deficit was rescued by prior open field (OF) exposure, and blocked by the protein synthesis inhibitor emetine, indicating that astrocytic GAT-3 influences consolidation via protein synthesis mechanisms. Similarly, pre-treatment with the proteasome inhibitor β-Lactacystin mitigated SNAP-induced deficits. Puromycin incorporation assays confirmed that SNAP reduced hippocampal protein synthesis. Additionally, SNAP administration before memory retrieval impaired expression, which was also rescued by OF exposure or β-Lactacystin infusion. In contrast, SNAP did not affect reconsolidation, a process impaired by Nipecotic Acid administration, a broader GABA transporter inhibitor. These findings reveal that GAT-3 function modulates memory consolidation and expression, but not its reconsolidation, and also is involved in the regulation of protein synthesis level. Our results highlight astrocytic GABA transport as a critical determinant of spatial memory regulation and a potential contributor to cognitive dysfunction in neurological disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.